22
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Post-COVID-19 syndrome (PCS) is a lingering disease with ongoing symptoms such as fatigue and cognitive impairment resulting in a high impact on the daily life of patients. Understanding the pathophysiology of PCS is a public health priority, as it still poses a diagnostic and treatment challenge for physicians.

          Methods

          In this prospective observational cohort study, we analyzed the retinal microcirculation using Retinal Vessel Analysis (RVA) in a cohort of patients with PCS and compared it to an age- and gender-matched healthy cohort ( n = 41, matched out of n = 204).

          Measurements and main results

          PCS patients exhibit persistent endothelial dysfunction (ED), as indicated by significantly lower venular flicker-induced dilation (vFID; 3.42% ± 1.77% vs. 4.64% ± 2.59%; p = 0.02), narrower central retinal artery equivalent (CRAE; 178.1 [167.5–190.2] vs. 189.1 [179.4–197.2], p = 0.01) and lower arteriolar-venular ratio (AVR; (0.84 [0.8–0.9] vs. 0.88 [0.8–0.9], p = 0.007). When combining AVR and vFID, predicted scores reached good ability to discriminate groups (area under the curve: 0.75). Higher PCS severity scores correlated with lower AVR ( R = − 0.37 p = 0.017). The association of microvascular changes with PCS severity were amplified in PCS patients exhibiting higher levels of inflammatory parameters.

          Conclusion

          Our results demonstrate that prolonged endothelial dysfunction is a hallmark of PCS, and impairments of the microcirculation seem to explain ongoing symptoms in patients. As potential therapies for PCS emerge, RVA parameters may become relevant as clinical biomarkers for diagnosis and therapy management.

          Trial registration

          This study was previously registered at ClinicalTrials (“All Eyes on PCS—Analysis of the Retinal Microvasculature in Patients with Post-COVID-19 Syndrome”. NCT05635552. https://clinicaltrials.gov/ct2/show/NCT05635552).

          Graphical abstract

          Persistent endothelial dysfunction in post-COVID-19 syndrome. Acute SARS-CoV-2 infection indirectly or directly causes endotheliitis in patients. N = 41 PCS patients were recruited and retinal vessel analysis was performed to assess microvascular endothelial function. Images of SVA and DVA are illustrative for RVA data analysis. For each PCS patient and healthy cohort, venular vessel diameter of the three measurement cycles was calculated and plotted on a diameter-time curve. Patients exhibited reduced flicker-induced dilation in veins (vFID) measured by dynamic vessel analysis (DVA) and lower central retinal arteriolar equivalent (CRAE) and arteriolar-venular ratio (AVR) and a tendency towards higher central retinal venular equivalent (CRVE) when compared to SARS-CoV-2 infection naïve participants. Created with BioRender.com

          Supplementary Information

          The online version contains supplementary material available at 10.1007/s10456-023-09885-6.

          Related collections

          Most cited references69

          • Record: found
          • Abstract: found
          • Article: not found

          The PHQ-9: validity of a brief depression severity measure.

          While considerable attention has focused on improving the detection of depression, assessment of severity is also important in guiding treatment decisions. Therefore, we examined the validity of a brief, new measure of depression severity. The Patient Health Questionnaire (PHQ) is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders. The PHQ-9 is the depression module, which scores each of the 9 DSM-IV criteria as "0" (not at all) to "3" (nearly every day). The PHQ-9 was completed by 6,000 patients in 8 primary care clinics and 7 obstetrics-gynecology clinics. Construct validity was assessed using the 20-item Short-Form General Health Survey, self-reported sick days and clinic visits, and symptom-related difficulty. Criterion validity was assessed against an independent structured mental health professional (MHP) interview in a sample of 580 patients. As PHQ-9 depression severity increased, there was a substantial decrease in functional status on all 6 SF-20 subscales. Also, symptom-related difficulty, sick days, and health care utilization increased. Using the MHP reinterview as the criterion standard, a PHQ-9 score > or =10 had a sensitivity of 88% and a specificity of 88% for major depression. PHQ-9 scores of 5, 10, 15, and 20 represented mild, moderate, moderately severe, and severe depression, respectively. Results were similar in the primary care and obstetrics-gynecology samples. In addition to making criteria-based diagnoses of depressive disorders, the PHQ-9 is also a reliable and valid measure of depression severity. These characteristics plus its brevity make the PHQ-9 a useful clinical and research tool.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The PHQ-9

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Post-acute COVID-19 syndrome

              Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in global healthcare crises and strained health resources. As the population of patients recovering from COVID-19 grows, it is paramount to establish an understanding of the healthcare issues surrounding them. COVID-19 is now recognized as a multi-organ disease with a broad spectrum of manifestations. Similarly to post-acute viral syndromes described in survivors of other virulent coronavirus epidemics, there are increasing reports of persistent and prolonged effects after acute COVID-19. Patient advocacy groups, many members of which identify themselves as long haulers, have helped contribute to the recognition of post-acute COVID-19, a syndrome characterized by persistent symptoms and/or delayed or long-term complications beyond 4 weeks from the onset of symptoms. Here, we provide a comprehensive review of the current literature on post-acute COVID-19, its pathophysiology and its organ-specific sequelae. Finally, we discuss relevant considerations for the multidisciplinary care of COVID-19 survivors and propose a framework for the identification of those at high risk for post-acute COVID-19 and their coordinated management through dedicated COVID-19 clinics.
                Bookmark

                Author and article information

                Contributors
                christoph.schmaderer@mri.tum.de
                Journal
                Angiogenesis
                Angiogenesis
                Angiogenesis
                Springer Netherlands (Dordrecht )
                0969-6970
                1573-7209
                28 July 2023
                28 July 2023
                2023
                : 26
                : 4
                : 547-563
                Affiliations
                [1 ]GRID grid.6936.a, ISNI 0000000123222966, School of Medicine, Klinikum Rechts Der Isar, Department of Nephrology, , Technical University of Munich, ; Ismaninger Str. 22, 81675 Munich, Germany
                [2 ]GRID grid.440943.e, ISNI 0000 0000 9422 7759, Faculty of Health Care, , Niederrhein University of Applied Sciences, ; Krefeld, Germany
                [3 ]GRID grid.411095.8, ISNI 0000 0004 0477 2585, Medizinische Klinik Und Poliklinik IV, , LMU University Hospital Munich, ; Ziemssenstraße 5, 80336 Munich, Germany
                [4 ]GRID grid.6936.a, ISNI 0000000123222966, School of Medicine, Klinikum Rechts Der Isar, Department of Clinical Chemistry and Pathobiochemistry, , Technical University of Munich, ; Ismaninger Str. 22, 81675 Munich, Germany
                [5 ]GRID grid.411095.8, ISNI 0000 0004 0477 2585, Department of Psychiatry and Psychotherapy, , LMU University Hospital Munich, ; Nußbaumstraße 7, 80336 Munich, Germany
                [6 ]GRID grid.411095.8, ISNI 0000 0004 0477 2585, Medizinische Klinik Und Poliklinik II, , LMU University Hospital Munich, ; Marchioninistraße 15, 81377 Munich, Germany
                [7 ]Department of Sport, Exercise and Health, Preventive Sports Medicine and Systems Physiology, University of Basel, ( https://ror.org/02s6k3f65) Basel, Switzerland
                [8 ]Aachen University of Applied Sciences, ( https://ror.org/04tqgg260) Heinrich-Mussmann-Str. 1, 52428 Jülich, Germany
                [9 ]GRID grid.15474.33, ISNI 0000 0004 0477 2438, School of Medicine, Institute for AI and Informatics in Medicine, , Technical University of Munich, Klinikum Rechts Der Isar, ; Ismaninger Str. 22, 81675 Munich, Germany
                [10 ]German Centre for Infection Research (DZIF), ( https://ror.org/028s4q594) Partner Site Munich, Munich, Germany
                Article
                9885
                10.1007/s10456-023-09885-6
                10542303
                37507580
                34743f0e-5f2b-4d12-b719-1cdef82aaef4
                © The Author(s) 2023, corrected publication 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 18 May 2023
                : 11 July 2023
                Funding
                Funded by: State of Bavaria through the Technical University Klinikum rechts der Isar
                Funded by: Technische Universität München (1025)
                Categories
                Original Paper
                Custom metadata
                © Springer Nature B.V. 2023

                Human biology
                endothelial dysfunction,long covid,post-covid-19 syndrome,retinal microvasculature

                Comments

                Comment on this article